查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496023

超音波診斷設備市場－2024年至2029年預測

Ultrasound Device Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

超音波診斷設備市場預計將以4.57%的複合年成長率成長，從2022年的71.45億美元市場規模成長到2029年的97.53億美元。

超音波技術利用聲波來創造人的內臟器官和內部運動的圖像。除了檢查孕婦的胎兒外，它還可以幫助識別內部感染並定位不適或水腫。超音波檢測技術也用於癌症檢測。與其他傳統技術相比，該技術是安全的。它也是一種具有成本效益的設備，並且需要更少的檢測時間。

超音波診斷設備的發展涉及多種因素，包括醫學領域的技術發展以及超音波技術在診斷和治療影像中的不斷擴大的應用。超音波可以應用於目標器官，而不是分析整個身體。這些因素正在增加這些技術在醫院等醫療機構中的使用，預計將在未來幾年推動超音波診斷設備市場的發展。

市場促進因素：

  • 由於慢性病的增加，預計超音波設備的需求將會增加。

患有心血管疾病、肺病、癌症和糖尿病等慢性疾病的人數每天都在增加。這一成長主要是由於近年來世界上很大一部分人口生活方式的改變、不健康的飲食習慣以及對身體健康整體不太重視的態度。這主要包括千禧世代。儘管如此，許多人還是更願意接受檢查，尤其是現在他們知道有這種類型的疾病。這就需要進行全面的身體檢查。

此外，超音波技術安全且具有成本效益，使其成為醫療專業人員進行篩檢和治療程序的首選。根據世界衛生組織（WHO）的報告，2020年將有近1,000萬人死於癌症，其中肺癌是最常見的癌症之一。

此外，還會出現乳癌、皮膚癌、結腸癌和直腸癌等新癌症。報告也發現，90%以上的高所得國家都可以獲得綜合治療。然而，低收入國家的可用性還不到 15%。 2021年6月，世界衛生組織（WHO）公佈調查結果，心血管疾病佔2019年全球死亡人數的32%。其中 85% 是心臟病發作和中風。為了解決這個問題，預篩選的趨勢越來越明顯。因此，預計未來幾年對超音波技術的需求將會增加。

全球許多醫療專業人員擴大採用影像導引和微創療法。超音波設備擴大被用作檢測癌症、腎結石和許多其他臨床病症的治療技術。超音波行業的製造商預計將因這些努力和進步而看到新的商機。由於超音波檢查實現的早期治療所帶來的一些積極成果，超音波技術在全世界廣泛應用。

市場限制因素：

  • 超音波設備的召回和低度開發國家的需求下降可能會限制市場成長。

由於收入低，低度開發國家仍無法取得先進技術。由於這些國家的需求較低，全球超音波診斷設備的成長可能會較低。此外，最近許多超音波診斷設備的召回也是阻礙市場成長的因素之一。例如，皇家飛利浦於 2020 年召回的一款 2 類產品存在冷卻功能缺陷，可能會在測試過程中傷害患者。這導致了新的超音波設備召回的威脅。

此外，超音波診斷設備需要適當的訓練。預計世界許多地區缺乏訓練有素的技術人員也將阻礙超音波技術在全球的推廣。

歐洲地區預計將佔很大佔有率。

歐洲先進的醫院和診斷設施醫療保健系統鼓勵使用超音波等醫療技術。該市場由超音波、彈性成像和 3D/4D 成像等技術創新驅動。隨著人口老化和慢性病的出現，超音波影像在診斷和監測方面的價值不斷增加。政府措施、研發活動和高度的醫療意識正在促進市場成長。

完善的法規環境可確保產品的安全性和有效性，增強醫療保健專業人員的信心並促進市場成長。法國、德國、英國、義大利等國家正在進行超音波研究和開發，隨著超音波設備臨床應用的擴大和早期商業化，歐洲超音波將佔有很大的市場佔有率。

主要進展

  • 2022年6月－邁瑞推出Imagyn I9超音波診斷設備，這是該公司首款婦產科專用產品。該系統由邁瑞的 ZONE Sonography® Technology+ 和人工智慧增強技術提供支援，可自動識別臨床場景，並在從成像最佳化到平面採集和量化的每個環節實現自動化。該解決方案涵蓋從孕前到產後護理的各個方面，為女性健康提供全面、聰明的方法。聲速校正、嵌裝玻璃流、智慧臉部和智慧平面 CNS 等先進技術可實現組織偵測、視覺化和平面偵測的自動化。 Imagyn I9 Ultrasound 可透過 Mindrei 值得信賴的合作夥伴購買。
  • 2022 年 4 月 - Sonex Health 推出 UltraGuideTFR 設備，該設備使用即時超音波引導進行扳機指釋放 (TFR) 手術。這種微創手術於今年稍早在市場上進行了有限的發布，它允許醫生透過小切口進行 TFR，並允許患者在幾天內恢復活動，而傳統手術則需要幾週時間。該裝置由 Sonex Health 聯合創始人 Darryl Burns 醫學博士和傑伊史密斯 (Jay Smith) 開發，旨在透過單個切口切開肌腱鞘和 A1 滑輪。
  • 2022 年 2 月 - Butterfly Network 與 Umbra Health 合作，提高床邊超音波資料的互通性。此次合作提高了 Butterfly 企業平台 Butterfly Blueprint(TM) 的擴充性，從而能夠跨醫院和衛生系統存取超音波資訊。 Ambra Health 利用 Butterfly Network 在整合來自主要健康系統（包括美國排名前 10 的醫院中的 8 家）的影像資訊方面的經驗。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章超音波診斷設備市場：依影像分類

  • 介紹
  • 腹部超音波影像
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 頸動脈和腹主動脈的超音波影像
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 產科超音波影像診斷
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 骨盆腔超音波影像
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章超音波診斷設備市場：依最終用戶分類

  • 介紹
  • 醫院
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 診所
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第7章超音波診斷設備市場：按地區

  • 介紹
  • 北美洲
    • 透過影像
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 透過影像
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 透過影像
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 透過影像
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 透過影像
    • 按最終用戶
    • 按國家/地區

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第9章 公司簡介

  • Koninklijke Philips NV
  • GE Healthcare
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare
  • Samsung Medison Co., Ltd.
  • Esaote
  • Hologic Inc.
  • Shimadzu Corporation
簡介目錄
Product Code: KSI061612165

The ultrasound device market is projected to grow at a CAGR of 4.57%, from a market size of US$7.145 billion in 2022 to US$9.753 billion in 2029.

The technology of ultrasound employs sound waves to create an image of a person's internal organs or internal bodily motions. Apart from inspecting the fetus in expectant mothers, it helps identify internal organ infections and pinpoint the location of discomfort or edema. Ultrasound techniques are also utilized for the purpose of cancer detection. This technique is safer as compared to other conventional techniques. In addition, they also consume less time in detection as well as is cost-effective devices.

Ultrasound device has various factors involved owing to the technological developments in the medical field, and expansions in applications of ultrasound techniques in diagnostic and therapeutic imaging. Rather than analyzing the entire body, ultrasound can be performed on the targeted organs. These factors are leading to an increase in the use of these technologies in healthcare facilities such as hospitals, which is expected to boost the ultrasound devices market in the years ahead.

Market Drivers:

  • Rising prevalence of chronic diseases is anticipated to increase the demand for ultrasound devices.

The population with chronic illnesses such as cardiovascular diseases, lung diseases, cancer, diabetes, and others is expanding day by day. This rise is basically due to changing ways of life, unhealthy eating habits, and overall thinking little of the body health of a major portion of the world population in recent years. This mainly includes the millennials. Still, many people prefer to be checked out, especially now that they are aware that these kinds of disorders exist. A comprehensive physical examination is necessary for this.

Moreover, due to ultrasound technology's safe and cost-effective properties, health professionals prefer using it for checkups and therapeutic procedures. As per the report by the World Health Organization, in 2020, nearly 10 million deaths were caused due to cancer, among which lung cancer is termed to be one of the most common cancers.

Furthermore, the new cases of cancer include breast cancer, skin cancer, colon, and rectum. The report also states that the availability of comprehensive treatment is in more than 90% of high-income countries. However, fewer than 15% of low-income nations have access to it. In June 2021, the World Health Organization released a study stating that cardiovascular illnesses accounted for 32% of fatalities worldwide in 2019. Of these, heart attacks and strokes accounted for 85%. To solve this issue, the inclination toward prior check-ups is growing. This expects an increase in demand for ultrasound technology in the coming years.

There is increasing adoption seen worldwide for image-guided and minimally invasive therapies by many health professionals. Ultrasound devices are transforming in use as a therapeutic technique for cancer, renal stones, and many other clinical conditions detections. Manufacturers in the ultrasound business are expected to have new opportunities as a result of these efforts and advances. Ultrasound technology has been used all across the world as a result of several positive outcomes brought about by early treatments made possible by ultrasound examinations.

Market Restraint:

  • Recalls of ultrasound devices and less demand in underdeveloped countries could limit the market growth.

Due to their low incomes, underdeveloped nations are still unable to take advantage of advanced technologies.The growth of ultrasound devices could be less globally due to lower demand in these countries. Additionally, recent recalls of many ultrasound devices are also one of the resistances to the market growth. For example, a class 2 product that was recalled by Koninklijke Philips in 2020 had a faulty cool function that could cause injury to a patient during the examination. This has created a threat to opt for a new recall of ultrasound devices.

Additionally, ultrasound equipment requires proper training since not every technician can handle the ultrasound equipment professionally without it. The lack of trained technicians in many parts of the world is also predicted to hamper the ultrasound technology expansion globally.

Europe region is predicted to hold a major share.

The sophisticated healthcare system in Europe, which consists of hospitals and diagnostic facilities, encourages the use of medical technology like ultrasonography. The market is driven by technological breakthroughs such as contrast-enhanced ultrasound, elastography, and 3D and 4D imaging. The value of ultrasonic imaging for diagnosis and monitoring is increased by the aging population and the occurrence of chronic illnesses. Government initiatives, research and development activities, and high healthcare awareness contribute to market growth.

A well-established regulatory environment ensures product safety and efficacy, instilling confidence in healthcare professionals and driving market growth. With ongoing research and developments in ultrasound, expansions in clinical applications, and early commercialization of ultrasound devices in countries such as France, Germany, the UK, and Italy, Europe is expected to hold a significant share of the ultrasound market in 2026.

Key Developments:

  • June 2022- Mindray launched the Imagyn I9 Ultrasound Machine, its first dedicated OB/GYN product. The system, powered by Mindray's ZONE Sonography(R) Technology+ and AI-enhanced technologies, uses auto-clinical scenario identification and automation at every point, from imaging optimization to plane acquisition and quantification. The solution offers a comprehensive, smart approach to women's health, covering various aspects from pre-pregnancy to post-partum care. Advanced technologies like Sound Speed Compensation, Glazing Flow, Smart Face, and Smart Planes CNS automate tissue detection, visualization, and plane detection. The Imagyn I9 Ultrasound is available through Mindray's trusted partners.
  • April 2022- Sonex Health launched its UltraGuideTFR device, which uses real-time ultrasound guidance for trigger finger release (TFR) procedures. This minimally invasive technique, used in a limited-market release earlier this year, allows physicians to perform TFR through a small incision, allowing patients to resume activities within days compared to weeks with traditional surgeries. The device, developed by Sonex Health's physician co-founders Dr. Darryl Barnes and Dr. Jay Smith, is designed to incise the tendon sheath and A1 pulley through a single incision.
  • February 2022- Butterfly Network partnered with Ambra Health to improve bedside ultrasound data interoperability. The partnership improves the scalability of Butterfly Blueprint(TM), Butterfly's enterprise platform, and access to ultrasound information across hospitals and health systems. Ambra Health leverages Butterfly Network's experience in integrating imaging information across major health systems, including eight of the top 10 hospitals in the U.S. The solution enables secure viewing and sharing of encounter-based ultrasound information, enhancing clinical decision-making.

Market Segmentation:

Ultrasound Device Market is segmented and analyzed as below:

By Imaging

  • Abdominal Ultrasound Imaging
  • Carotid & Abdominal Aorta Ultrasound Imaging
  • Obstetric Ultrasound Imaging
  • Pelvic Ultrasound Imaging
  • Others

By End-User

  • Hospitals
  • Clinics

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ULTRASOUND DEVICE MARKET BY IMAGING

  • 5.1. Introduction
  • 5.2. Abdominal Ultrasound Imaging
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Carotid & Abdominal Aorta Ultrasound Imaging
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Obstetric Ultrasound Imaging
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Pelvic Ultrasound Imaging
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Others
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. ULTRASOUND DEVICE MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Clinics
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. ULTRASOUND DEVICE MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Imaging
    • 7.2.2. By End-User
    • 7.2.3. By Country
      • 7.2.3.1. USA
        • 7.2.3.1.1. Market Opportunities and Trends
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Opportunities and Trends
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Opportunities and Trends
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Imaging
    • 7.3.2. By End-User
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Opportunities and Trends
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Opportunities and Trends
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Opportunities and Trends
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Imaging
    • 7.4.2. By End-User
    • 7.4.3. By Country
      • 7.4.3.1. Germany
        • 7.4.3.1.1. Market Opportunities and Trends
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. France
        • 7.4.3.2.1. Market Opportunities and Trends
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. UK
        • 7.4.3.3.1. Market Opportunities and Trends
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Others
        • 7.4.3.4.1. Market Opportunities and Trends
        • 7.4.3.4.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Imaging
    • 7.5.2. By End-User
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Opportunities and Trends
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Opportunities and Trends
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Others
        • 7.5.3.3.1. Market Opportunities and Trends
        • 7.5.3.3.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Imaging
    • 7.6.2. By End-User
    • 7.6.3. By Country
      • 7.6.3.1. China
        • 7.6.3.1.1. Market Opportunities and Trends
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. India
        • 7.6.3.2.1. Market Opportunities and Trends
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. Japan
        • 7.6.3.3.1. Market Opportunities and Trends
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. South Korea
        • 7.6.3.4.1. Market Opportunities and Trends
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Taiwan
        • 7.6.3.5.1. Market Opportunities and Trends
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Thailand
        • 7.6.3.6.1. Market Opportunities and Trends
        • 7.6.3.6.2. Growth Prospects
      • 7.6.3.7. Indonesia
        • 7.6.3.7.1. Market Opportunities and Trends
        • 7.6.3.7.2. Growth Prospects
      • 7.6.3.8. Others
        • 7.6.3.8.1. Market Opportunities and Trends
        • 7.6.3.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Koninklijke Philips N.V.
  • 9.2. GE Healthcare
  • 9.3. CANON MEDICAL SYSTEMS CORPORATION
  • 9.4. Hitachi
  • 9.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 9.6. Siemens Healthcare
  • 9.7. Samsung Medison Co., Ltd.
  • 9.8. Esaote
  • 9.9. Hologic Inc.
  • 9.10. Shimadzu Corporation